Table 2 Prevalence of preexisting medical conditions of the study population
n | Beta-Blockade (n = 37) | No Beta-Blockade (n = 69) | P-value | |
|---|---|---|---|---|
Arterial hypertension | 103 | 35 (94.6%) (n = 37) | 40 (60.6%) (n = 66) | < 0.0012 |
Coronary artery disease | 102 | 8 (22.2%) (n = 36) | 7 (10.6%) (n = 66) | 0.1132 |
Peripheral arterial disease | 106 | 4 (10.8%) | 2 (2.9%) | 0.0932 |
Ischemic stroke/TIA | 101 | 0 | 3 (4.7%) | 0.1812 |
Atrial fibrillation | 106 | 7 (18.9%) | 5 (7.2%) | 0.0712 |
Chronic kidney injury | 106 | 10 (27.0%) | 6 (8.7%) | 0.0122 |
COPD/Asthma | 106 | 6 (16.2%) | 5 (7.2%) | 0.1492 |
Diabetes mellitus | 103 | 11 (29.7%) (n = 37) | 14 (21.2%) (n = 66) | 0.3332 |
Hyperlipo-proteinemia | 106 | 19 (51.4%) | 15 (21.7% | 0.0022 |
Smoking | 103 | 7 (20%) (n = 35) | 6 (8.8%) (n = 68) | 0.1062 |
Package years | 87 | 0 (0–7.5) (n = 27) | 0 (0–11.9) (n = 60) | 0.6981 |
Alcohol consumption: | 96 | n = 34 | n = 62 | 0.2382 |
Non-harmful | 91 | 31 (91.2%) | 60 (96.8%) | |
Harmful | 5 | 3 (8.8%) | 2 (3.2%) |